Chart, page-117

First 117 Last

Share
Profile

Follow
usernamedude

911 Posts.

109

12/10/17

13:48

Post #: 27855039
Share

Originally posted by Patong1 ↑

I've been doing this for a long time. And I'm not saying charting and technical analysis is the only way. I've never said that, however, they do cut through alot of BS. Most of the time a technical signal front runs the fundamentals and can show what the insiders are doing. I have many examples. KAI , technical scan said buy on the open tomorrow, Was long around .03 and out .08 in 4 days. SCI in at .026 out today .055. No fundamental analysis at all. Yesterday signal buy EURNZD 1.6690 closed + 50 pips. Scan from last night. CZR, REX, GSC., and much more. I actually post very little of my actual live trading. I don't just jump in on the scan, Scan results are just the beginning of the analysis. One thing I do know regardless of the fundamentals when then technicals line up with the fundamentals it offers a higher probability trade.. Presently with BAR they don't line up. In time they will, then I will know to get in. ( Plus I still own that 100,000 from the 40 cent issue.) Its call confluence, confirmation whatever. In today's market, one needs to use all the tools in their toolbox and what suits their style. Present buying looks ok as long as someone doesn't smash orders from .04-.042.

Time and timing are two completing different aspects of trading.

Expand

plz teach me your ways sensai

BAR Price at posting: 4.3¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 76 more messages in this thread...

First 117 Last

Add GSR (ASX) to my watchlist

Chart, page-117

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News